Trademark: 97267617
Word
CTX001
Status
Dead
Status Code
602
Status Date
Tuesday, March 7, 2023
Serial Number
97267617
Mark Type
4000
Filing Date
Tuesday, February 15, 2022
Abandoned Date
Thursday, February 16, 2023
Trademark Owner History
Vertex Pharmaceuticals Incorporated
Classifications
5 Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia
44 Providing health information to patients, caregivers and health care professionals; providing health care information relating to blood disorders, and information relating to the therapeutic properties of pharmaceuticals used for treating blood disorders
42 Providing medical and scientific research information in the field of blood disorders, and in the field of pharmaceuticals for treating blood disorders
CTX ZERO ZERO ONE
Trademark Events
Mar 7, 2023
Abandonment Notice E-Mailed - Failure To Respond
Mar 7, 2023
Abandonment Notice Mailed - Failure To Respond
Mar 7, 2023
Abandonment - Failure To Respond Or Late Response
Aug 15, 2022
Notification Of Non-Final Action E-Mailed
Aug 15, 2022
Non-Final Action E-Mailed
Aug 15, 2022
Non-Final Action Written
Aug 8, 2022
Assigned To Examiner
Apr 10, 2022
Teas Amendment Entered Before Attorney Assigned
Apr 10, 2022
Teas Voluntary Amendment Received
Feb 18, 2022
New Application Office Supplied Data Entered
Feb 18, 2022
New Application Entered
QUANTUMSUBRO
¡VAMOS!
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov